| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/23/1999 | US5874402 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 02/23/1999 | US5874401 Cedar pollen protein and use thereof in treating, preventing, and diagnosing pollenosis |
| 02/23/1999 | US5874400 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 02/23/1999 | US5874399 Progenitor B cell stimulating factor |
| 02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
| 02/23/1999 | US5874299 Transgene coding for human immunoglobulin heavy chain variable regions, d regions, j regions, mu constant region, and gamma constant region where gamma region is closer to mu region than in natural locus |
| 02/23/1999 | US5874290 Nucleotide and amino acid sequences of a D2-2 gene associated with brain tumors and methods based thereon |
| 02/23/1999 | US5874286 Tumor proteins |
| 02/23/1999 | US5874285 Polynucleotide encoding a novel human nm23-like protein |
| 02/23/1999 | US5874283 Mammalian flap-specific endonuclease |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874267 Expression of surface layer proteins |
| 02/23/1999 | US5874264 Retrovirus |
| 02/23/1999 | US5874255 DNA encoding humanized antibodies specific for the ganglioside GM2 |
| 02/23/1999 | US5874254 FGF-5 analogous protein, and pharmaceutical composition containing the same |
| 02/23/1999 | US5874253 Expression vectors and genetic engineering |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874250 DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3 |
| 02/23/1999 | US5874248 Polynucleotides and codes |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874244 Human NADH dehydrogenase subunits and DNA thereof |
| 02/23/1999 | US5874243 OLRCC15 receptor |
| 02/23/1999 | US5874241 Clock gene and gene product |
| 02/23/1999 | US5874240 Human 4-1BB receptor splicing variant |
| 02/23/1999 | US5874239 Biotinylation of proteins |
| 02/23/1999 | US5874238 A dna molecule encoding a mutant mammalian c-reactive protein which has at least one cysteine deleted or replaced by other amino acid, for binding aggregated immunoglobulin and immune complexes, treating infections, endotoxic shock, cancer |
| 02/23/1999 | US5874234 Assay for a novel mammalian protein associated with uncontrolled cell division |
| 02/23/1999 | US5874228 Methods and kits for determining the levels of IGE-BF |
| 02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
| 02/23/1999 | US5874225 Cell line from human rhabdomyosarcoma cell line te671. differentiated cells are characterized by great enlargement |
| 02/23/1999 | US5874224 Growth factor receptor binding protein |
| 02/23/1999 | US5874211 Chemokine expressed in eosinophils |
| 02/23/1999 | US5874209 Regulation of transcription factor, NF-IL6/LAP |
| 02/23/1999 | US5874109 Incorporation of biological molecules into bioactive glasses |
| 02/23/1999 | US5874099 Methods for making immunoisolatary implantable vehicles with a biocompatible jacket and a biocompatible matrix core |
| 02/23/1999 | US5874087 Modified plant viruses as vectors |
| 02/23/1999 | US5874086 Synthetic polypeptide analogs of parathyroid hormone (pth), parathyroid hormone related peptide (pthrp), and of the physiologically active truncated homologs and analogs of pth and pthrp; forming an amphipathic alpha-helix |
| 02/23/1999 | US5874085 A drug comprising at least one cytokine stimulants and a b cell activator selected from a cell surface protein and bacterial lipopolysaccharide |
| 02/23/1999 | US5874083 Proteins and complexes for immune response |
| 02/23/1999 | US5874082 Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation |
| 02/23/1999 | US5874081 Therapeutic compositions and methods for inhibition and treatment of tumor associated angiogenesis |
| 02/23/1999 | US5874080 Administering a therapeutic polypeptide antiallergens to inhabit elastase release by neutrophils |
| 02/23/1999 | US5874079 Exposing said bacteria to a bactericidal-effective amount of an isolated type ii phospholipase a2 |
| 02/23/1999 | US5874077 Human til cells expressing recombinant TNF prohormone |
| 02/23/1999 | US5874076 Immunomodulators; antitumor,-carcinogenic agents; extracted from a recombinant microorganism; separated from reduced interleukin (cysteine) from the oxidized interleukin (cystine) |
| 02/23/1999 | US5874075 Stable protein: phospholipid compositions and methods |
| 02/23/1999 | US5874071 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 02/23/1999 | US5873811 Method for inhibiting restonosis at a vessel wall region |
| 02/23/1999 | US5873358 Inhaling |
| 02/23/1999 | CA2162042C Enteral nutritional product |
| 02/23/1999 | CA1340409C Functionally specific antibodies |
| 02/23/1999 | CA1340401C Cell surface protein, process for its preparation, and the use of a cell surface protein thus obtained |
| 02/21/1999 | CA2241428A1 Asp5 |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2241433A1 Novel compounds |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999008109A2 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
| 02/18/1999 | WO1999007893A1 ISOLATION OF A NOVEL SENESCENCE-FACTOR GENE, p23 |
| 02/18/1999 | WO1999007891A1 90 human secreted proteins |
| 02/18/1999 | WO1999007868A1 Immunologically privileged cells and uses thereof |
| 02/18/1999 | WO1999007856A1 Novel metalloprotease |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007854A2 Serine/threonine kinase, and uses related thereto |
| 02/18/1999 | WO1999007851A1 CANINE INTERLEUKIN 18, CANINE INTERLEUKIN 1β CONVERTASE, DNA SEQUENCES ENCODING THE SAME, PROCESS FOR PRODUCING INTERLE UKIN 18, AND REMEDIES FOR CANINE IMMUNOLOGICAL DISEASES |
| 02/18/1999 | WO1999007850A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 02/18/1999 | WO1999007849A2 Human reticulocalbin isoforms |
| 02/18/1999 | WO1999007846A1 Protein having pdz domain sequence |
| 02/18/1999 | WO1999007844A2 Methods and compositions for treatment of restenosis |
| 02/18/1999 | WO1999007843A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 02/18/1999 | WO1999007840A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | WO1999007839A2 Immunoprotective influenza antigen and its use in vaccination |
| 02/18/1999 | WO1999007835A2 1-alpha-hydroxylase |
| 02/18/1999 | WO1999007741A1 Meningococcus vaccine comprising the valence of bz83 strain |
| 02/18/1999 | WO1999007740A2 Lipocalin homologs |
| 02/18/1999 | WO1999007739A2 Dna encoding the human synapsin iii gene and uses thereof |
| 02/18/1999 | WO1999007737A2 Lsr receptor, cloning and uses |
| 02/18/1999 | WO1999007736A2 Lipoprotein-regulating medicaments |
| 02/18/1999 | WO1999007734A2 Hepatitis c inhibitor peptide analogues |
| 02/18/1999 | WO1999007733A2 Hepatitis c inhibitor peptides |
| 02/18/1999 | WO1999007732A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007731A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/18/1999 | WO1999007730A1 SELECTIVE FACTOR Xa INHIBITORS CONTAINING A FUSED AZEPINONE STRUCTURE |
| 02/18/1999 | WO1999007729A2 Peptides having potassium channel opener activity |
| 02/18/1999 | WO1999007728A2 Linear peptides derived from antibiotic peptides, preparation and use for vectoring active substances |
| 02/18/1999 | WO1999007725A1 EXPRESSION OF NEUROGENIC bHLH GENES IN PRIMITIVE NEUROECTODERMAL TUMORS |
| 02/18/1999 | WO1999007724A1 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 02/18/1999 | WO1999007414A1 Vectors derived from antibodies for transferring substances into cells |
| 02/18/1999 | WO1999007413A1 Substance p inhibitors in combination with nmda-blockers for treating pain |
| 02/18/1999 | WO1999007410A1 Pharmaceutical composition with neurotrophic-like biological activity |
| 02/18/1999 | WO1999007409A1 Product comprising at least a double stranded rna combined with at least an antiviral agent |
| 02/18/1999 | WO1999007408A1 Protein factor associated with a neuro-degenerative or autoimmune and/or inflammatory disease |
| 02/18/1999 | WO1999007407A1 Heparin-binding growth factor (hbgf) polypeptides |
| 02/18/1999 | WO1999007406A1 C1q AND COLLECTIN RECEPTOR |
| 02/18/1999 | WO1999007405A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF αvβ6 |
| 02/18/1999 | WO1999007404A1 Novel exendin agonist compounds |
| 02/18/1999 | WO1999007403A1 Nootropic drugs |
| 02/18/1999 | WO1999007402A1 METHOD TO PREVENT ACCELERATED ATHEROSCLEROSIS USING (sRAGE) SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS |
| 02/18/1999 | WO1999007401A2 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 02/18/1999 | WO1999007400A1 Dietary supplements containing natural ingredients |
| 02/18/1999 | WO1999007394A1 Use of herpes vectors for tumor therapy |